已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Outcomes of BCG vs upfront radical cystectomy for high‐risk non‐muscle‐invasive bladder cancer

膀胱切除术 医学 膀胱癌 危险系数 倾向得分匹配 比例危险模型 泌尿科 内科学 累积发病率 回顾性队列研究 置信区间 入射(几何) 队列 癌症 肿瘤科 外科 物理 光学
作者
Pietro Scilipoti,Mattia Longoni,Mario de Angelis,Paolo Zaurito,Aleksander Ślusarczyk,Francesco Soria,Benjamin Pradere,Wojciech Krajewski,David D‘Andrea,Andrea Mari,Francesco Del Giudice,Renate Pichler,José Daniel Subiela,Gautier Marcq,Andrea Gallioli,Luca Afferi,Riccardo Mastroianni,Giuseppe Simone,Simone Albisinni,Laura S. Mertens
出处
期刊:BJUI [Wiley]
卷期号:136 (1): 47-54 被引量:7
标识
DOI:10.1111/bju.16675
摘要

Objective To assess the oncological outcomes of patients with high‐risk (HR) and very high‐risk (VHR) non‐muscle‐invasive bladder cancer (NMIBC) treated with upfront radical cystectomy (RC) vs Bacillus Calmette–Guérin (BCG) instillations from a contemporary European multicentre cohort. Patients and Methods We conducted a retrospective analysis of 1491 patients diagnosed with HR‐ or VHR‐NMIBC from a European multicentre database between 2015 and 2024. Patients were included if they received either upfront RC or at least five doses of BCG. A 1:1 propensity score matching (PSM) according to clinically relevant variables was applied. Progression was defined as muscle‐invasive or metastatic disease. Cumulative incidence plots and multivariable competing risk regression models addressing cancer‐specific mortality (CSM) were fitted. Results Among the 1221 patients with HR‐ ( n = 1221 [90%]) or VHR‐NMIBC ( n = 121 [10%]), 87 (7.1%) underwent upfront RC. The median follow‐up was 2.6 years. After PSM (87 vs 87 patients), the 5‐year CSM rate was similar in patients treated with BCG (13%) vs their upfront RC counterparts (16%) (hazard ratio: 1.77, 95% confidence interval [CI] 0.66–4.73; P = 0.3). Of the 1134 patients who initially received BCG, 73 (6.6%) eventually required delayed RC, with 34 (47%) progressing to muscle‐invasive bladder cancer before delayed RC. The 3‐year CSM rate was comparable in upfront RC (13%) vs delayed RC (11%) among non‐progressing patients ( P = 0.3). However, patients who progressed before delayed RC had worse 3‐year CSM relative to those who did not (13% vs 31%, hazard ratio: 0.32, 95% CI 0.13–0.83; P = 0.018). Conclusion Within a European cohort of patients with HR‐ and VHR‐NMIBC, upfront RC was rarely performed. Patients treated with BCG did not exhibit a CSM disadvantage relative to their upfront RC counterparts. After matching, long‐term CSM was similar between BCG therapy and upfront RC. Delayed RC, led to worse outcomes if performed after progression, but matched upfront RC when performed before progression, underscoring importance of timely surgery.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
乐观的黎云完成签到 ,获得积分10
1秒前
子平完成签到 ,获得积分0
1秒前
可爱的函函应助Ywq采纳,获得10
4秒前
yy发布了新的文献求助10
5秒前
6秒前
6秒前
wen完成签到,获得积分10
7秒前
自觉千凝完成签到 ,获得积分10
8秒前
9秒前
Annie完成签到,获得积分10
9秒前
Sharon发布了新的文献求助10
10秒前
芸栖发布了新的文献求助10
11秒前
幸运幸福完成签到,获得积分10
12秒前
苶凉完成签到,获得积分10
12秒前
14秒前
Annie发布了新的文献求助10
15秒前
真的很困完成签到 ,获得积分10
15秒前
忧心的冷风完成签到,获得积分10
17秒前
华仔应助莫琳采纳,获得10
18秒前
19秒前
19秒前
123发布了新的文献求助10
19秒前
20秒前
打打应助科研通管家采纳,获得10
21秒前
伯云完成签到,获得积分10
21秒前
Akim应助科研通管家采纳,获得10
21秒前
Danzel应助科研通管家采纳,获得26
21秒前
DW应助科研通管家采纳,获得10
21秒前
21秒前
21秒前
丘比特应助科研通管家采纳,获得10
21秒前
21秒前
完美世界应助科研通管家采纳,获得10
22秒前
cdercder应助科研通管家采纳,获得10
22秒前
ALAI发布了新的文献求助10
23秒前
可爱南风发布了新的文献求助10
24秒前
28秒前
芸栖发布了新的文献求助10
29秒前
传奇3应助XPX采纳,获得10
29秒前
29秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Essentials of Carbohydrate Chemistry and Biochemistry, 4th Edition 600
Organizational Behavior 510
Management and the Arts 510
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
Rosenblum, Global Change Biology 500
CLSI VET01S-2024 Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals (7th Ed) 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 化学工程 工程类 有机化学 物理 复合材料 生物化学 内科学 细胞生物学 基因 遗传学 免疫学 冶金 光电子学 癌症研究
热门帖子
关注 科研通微信公众号,转发送积分 7772189
求助须知:如何正确求助?哪些是违规求助? 9314613
关于积分的说明 20339278
捐赠科研通 7357604
什么是DOI,文献DOI怎么找? 3316905
关于科研通互助平台的介绍 2465377
邀请新用户注册赠送积分活动 2331889